Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06266403 · ClinicalTrials.gov registry record · NA
Evaluating Verbal Communication in Structured Interactions: Theoretical and Clinical Implications
A NA study of Amyotrophic Lateral Sclerosis, sponsored by Penn State University.
- Recruiting
- Registry status
- NA
- Development phase
- 300
- Enrollment target
- 1
- Study location
NCT06266403 is a NA study of Amyotrophic Lateral Sclerosis that is actively recruiting participants, run by Penn State University. The registered enrollment target is 300 participants, below the 895-participant average among 102 other Amyotrophic Lateral Sclerosis trials with a reported enrollment target (66% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06266403, a NA study of Amyotrophic Lateral Sclerosis, is actively recruiting participants, sponsored by Penn State University.
- RECRUITING
- Registry status
- NA
- Development phase
- 300 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to learn about the effect of communicative interaction on verbal communication in people with amyotrophic lateral sclerosis (ALS) and age-matched speakers. The question is, What are the effects of communicative interaction on verbal communication in people with ALS? Participants will read words and sentences while they are in a solo setting and interactive setting.
Conditions Studied
Interventions
- BEHAVIORAL Structured Communicative Interaction
- BEHAVIORAL Clear Speech
- BEHAVIORAL Unstructured communicative interaction
- BEHAVIORAL Clear Speech Structured Communicative Interaction
Study Locations (1)
Pennsylvania
- Speech Core, Pennsylvania State University - University Park
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2024-11-05 |
| Est. Completion | 2029-02-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06266403
The ClinicalTrials.gov registry entry for NCT06266403 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 895-participant average among 102 other Amyotrophic Lateral Sclerosis trials with a reported enrollment target (66% lower). The listed sponsor is Penn State University, which has 219 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Amyotrophic Lateral Sclerosis appearing as the primary indexed condition, and to 4 interventions - of which Structured Communicative Interaction is the first listed.
NCT06266403 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT06266403 about?
NCT06266403 is a clinical study titled "Evaluating Verbal Communication in Structured Interactions: Theoretical and Clinical Implications". The goal of this clinical trial is to learn about the effect of communicative interaction on verbal communication in people with amyotrophic lateral sclerosis (ALS) and age-matched speakers. The question is, What are the effects of communicative interaction on verbal communication in people with AL...
What is the current status of trial NCT06266403?
This trial is currently recruiting. It is a NA study. The enrollment target is 300 participants. The study started on 2024-11-05. Estimated completion is 2029-02-28.
What conditions does trial NCT06266403 study?
This clinical trial studies the following conditions: Amyotrophic Lateral Sclerosis.
What interventions are being tested in trial NCT06266403?
The interventions under investigation include: Structured Communicative Interaction (BEHAVIORAL), Clear Speech (BEHAVIORAL), Unstructured communicative interaction (BEHAVIORAL), Clear Speech Structured Communicative Interaction (BEHAVIORAL).
Who is sponsoring clinical trial NCT06266403?
This trial is sponsored by Penn State University, which has 219 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06266403 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Amyotrophic Lateral Sclerosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia (BG-Speech-02)
RECRUITING · NA
-
Assessing Perceptual Effects of Interactive Tasks
RECRUITING · NA
-
Spinal Cord Associative Plasticity for ALS
RECRUITING · NA
-
Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Neuromuscular Disease
RECRUITING · NA
-
Oral Intake of Enteral Nutrition Formula Preceding Placement and Feeding Via GTube and Its Impact on Formula Intolerance in pALS
RECRUITING · NA
-
Precise Robotically IMplanted Brain-Computer InterfacE
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.